2023
DOI: 10.3390/cancers15225458
|View full text |Cite
|
Sign up to set email alerts
|

From Non-Alcoholic Steatohepatitis (NASH) to Hepatocellular Carcinoma (HCC): Epidemiology, Incidence, Predictions, Risk Factors, and Prevention

Benedetta Maria Motta,
Mario Masarone,
Pietro Torre
et al.

Abstract: Non-alcoholic fatty liver disease (NAFLD) affects up to a quarter of the adult population in many developed and developing countries. This spectrum of liver disease ranges from simple steatosis to non-alcoholic steatohepatitis (NASH) and cirrhosis. The incidence of NASH is projected to increase by up to 56% over the next 10 years. There is growing epidemiological evidence that NAFLD has become the fastest-growing cause of hepatocellular carcinoma (HCC) in industrialized countries. The annual incidence of HCC v… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(7 citation statements)
references
References 138 publications
0
5
0
Order By: Relevance
“…These patients also present a higher degree of fibrosis and the possibility of progressing to cirrhosis in proportion to BMI and abdominal circumference. This results from hepatic immune activation, leading to secondary inflammation and fibrosis, heightening the risk of HCC development [ 58 , 59 ]. Additionally, obesity also shows an association and a worse prognosis among patients who consume alcohol.…”
Section: Discussionmentioning
confidence: 99%
“…These patients also present a higher degree of fibrosis and the possibility of progressing to cirrhosis in proportion to BMI and abdominal circumference. This results from hepatic immune activation, leading to secondary inflammation and fibrosis, heightening the risk of HCC development [ 58 , 59 ]. Additionally, obesity also shows an association and a worse prognosis among patients who consume alcohol.…”
Section: Discussionmentioning
confidence: 99%
“…Since obesity was identified as an important risk factor for many cancers, numerous studies were conducted to evaluate how effective the therapies for cancer prevention (surgical or pharmacological) against obesity proved to be [49,50]. Weight reduction (which correlates with a low-fat and -sugar diet and a high dietary intake of fresh fruit and vegetables, and their associated nutrients like fiber, antioxidants, and polyphenols) together with a healthy lifestyle and regular exercise may contribute to the prevention of pancreatic cancer [50,51].…”
Section: Discussionmentioning
confidence: 99%
“…In patients with MASLD/MASH, HCC can develop with or without existing cirrho- In patients with MASLD/MASH, HCC can develop with or without existing cirrhosis, although liver cirrhosis is the strongest predictor for HCC development. The annual incidence of HCC in patients with cirrhotic MASH is up to 12% [29]. HCC develops in these patients due to the combination of insulin resistance, damage to the mitochondria from the accumulation of fat, inflammation, and chronic dysregulation of cytokines [29].…”
Section: Liver Diseases: Masld Mash and Hccmentioning
confidence: 99%
“…The annual incidence of HCC in patients with cirrhotic MASH is up to 12% [29]. HCC develops in these patients due to the combination of insulin resistance, damage to the mitochondria from the accumulation of fat, inflammation, and chronic dysregulation of cytokines [29]. Despite advances in HCC therapies, including the availability of immune checkpoint inhibitors, further research is greatly needed, as the overall survival with the current systemic therapies is limited (average 5-year survival as low as 2.5% for advanced metastatic disease) [30,31].…”
Section: Liver Diseases: Masld Mash and Hccmentioning
confidence: 99%